A new landmark study at the University of Maryland School of Medicine found that COVID-19 patients taking a daily, low-dose aspirin to protect against cardiovascular disease significantly lowered the risk of death and complications from COVID-19.
A new landmark study at the University of Maryland School of Medicine found that COVID-19 patients taking a daily, low-dose aspirin to protect against cardiovascular disease significantly lowered the risk of death and complications from COVID-19.